Medicinal cannabis player MGC Pharma has easily raised $10 million as it looks to fast-track acquisitions and accelerate development of its cannabis-derived products. MGC will use the funds to ramp up its medical R&D program and expand sales of its cosmetics and dermatological cannabis-derived lines with the latter to fund the former.
19/03/2017 - 08:48
MGC Pharma raises $10m to fast-track medical cannabis development
By Matt Birney
19/03/2017 - 08:48
Related Data & Insights
-
-
Rank Company Revenue 125th Argent BioPharma $4.2m 201 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Data & Insights
Mentioned Organisations
Mentioned People
Related Articles
01 Dec 2023
Board Moves December 1, 2023
28 Jul 2023
Board Moves July 28, 2023
30 Jun 2023
MGC Pharma sacks senior staffer
07 Jun 2023
Board Moves May 31 to June 2, 2023
01 Mar 2023
Board Moves March 1, 2023
03 Jan 2023
Board Moves January 3, 2023
Subscribe today for award-winning, unbiased and trusted journalism
Subscription OptionsX